A selective alternative pathway complement inhibitor for treatment of paroxysmal nocturnal hemoglobinuria
H. Sülzen, H. Tulmin, M. Hajek, J. Cermak, A. Kadlecova, P. Pompach, J. Votrubova, M. Zoltner, S. Zoll
This paper introduces SH-01, a novel recombinant protein that selectively inhibits the complement alternative pathway, showing efficacy in preventing PNH-related erythrocyte lysis and reduced infection risk compared to current treatments.
bioRxiv · Jun 23, 2024 · PreprintImmunology